Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide: The Newest Wave in Weight Loss The Drjonespodcast What is the pipeline for future medications for obesity? International Journal of Obesity Cagrilintide and tirzepatide are NOT medically equivalent, and one cannot replace the other like a refill. , Tirzepatide is FDA approved and dosed once weekly with careful titration based on Cagrilintide Semaglutide combo Improves Weight Loss and Glycemic Control in T2DM, finds trial CagriSema misses noninferiority vs tirzepatide in REDEFINE 4; Novo Nordisk shares fall 15% iPharmaCenter